Recon: Sanofi expects EU decision on COVID booster within weeks; FDA reviewers unconvinced ahead of second Amylyx adcomm

ReconReconBiologicsBiotechnologyDiagnosticsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy